Surgically Induced Astigmatism of Temporal Versus Nasal Clear Corneal Phacoemulsification
- Conditions
- Surrgical Induced Astigmatism
- Interventions
- Procedure: phacoemulsification and intraocular lens implantation
- Registration Number
- NCT00521833
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
To compare the short-term astigmatic outcomes of phacoemulsification cataract surgery and intraocular lens implantation using temporal versus nasal clear corneal incisions.
- Detailed Description
In a clinical trial, consecutive eyes with senile cataract underwent phacoemulsification with implantation of a 6.0 mm foldable hydrophobic acrylic intraocular lens through a 3.2 mm horizontal clear cornea incision at 180 degrees (temporal incision in right eyes, nasal incision in left eyes). Keratometric astigmatism was measured preoperatively and one and four weeks and 6 months after surgery. Surgically induced astigmatism (SIA) was calculated by the vector analysis method using the Holladay-Cravy-Koch formula. Patients with history of diabetes mellitus, connective tissue disorders, steroid use, previous ocular surgery, with the rule astigmatism \>1D, pseudoexfoliation and any corneal pathology were excluded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- All the patients with senile cataract
- Previously operated eyes
- Presence of corneal pathology
- Pseudo exfoliation
- With-the-rule (WTR) astigmatism >1 D
- Presence of diabetes mellitus
- History of connective tissue disease
- Consumption of systemic steroids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 phacoemulsification and intraocular lens implantation Nasal (Left eye) 1 phacoemulsification and intraocular lens implantation Temporal (right eye)
- Primary Outcome Measures
Name Time Method Total and Surgical Induced Astigmatism At 1 and 4 weeks and 6 month after surgery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ophthalmic research center
🇮🇷Tehran, Iran, Islamic Republic of